ArticleJournal of neurology2025

Stratify and ImmunoWELL JCV tests performances in a real-world multiple sclerosis cohort: possible clinical implications of biosimilar Natalizumab use.

Simone Guerrieri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.